跳至主要内容
临床试验/NCT04342065
NCT04342065已完成2 期

Efficacy of Pre-emptive Different Doses of Oral Pregabalin Versus Celecoxib on Sevoflurane and Analgesic Consumption in Patients Subjected for Elective Lumbar Spine Fixation Surgery: a Randomized Controlled Trial

South Egypt Cancer Institute1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2019年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
pain control

研究概览

简要总结

The anti-epileptic drugs such as gabapentin and other non-steroidal anti-inflammatory drugs (NSAID) such as celecoxib were used as a part of multimodal analgesia to control such pain. Gabapentin is an anticonvulsant drug that has analgesic effect in post-herpetic neuralgia, diabetic neuropathy, and neuropathic pain. Celecoxib is one of the NSAIDs, that its analgesic effect is reported in various studies by cyclooxygenase-2 (COX-2) inhibitor.

The aim of this randomized double-blinded study was to asses and compare the efficacy of using gabapentin versus celecoxib as a part of multimodal analgesia in perioperative hemodynamic control and pain relief in patients underwent posterior approach lumbar spine disc fixation surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
21 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •American society of anesthesiologists (ASA) I and II, aged between 21-60 years old scheduled to undergo elective posterior approach lumbar spine disc surgery

排除标准

  • •Patients with a known sensitivity to celecoxib or pregabalin, psychotic disorder or cognitive impairment, history of drug dependency or substance addiction, history of chronic medical disease, the presence of coagulation disorders or pregnancy, were excluded from the study.

研究组 & 干预措施

Group (C)

Active Comparator

received celecoxib 200 mg 2 hours preoperative and the same dose 6 hours postoperative.

干预措施: Celecoxib capsules (Drug)

Group (G)

Active Comparator

received gabapentin 300 mg capsule 2 hours preoperative and the same dose 6 hours postoperative.

干预措施: Pregabalin 150mg (Drug)

结局指标

主要结局

pain control

时间窗: Change from Baseline Visual Analogue Scale every 4 hours for 48 hours (0=no pain 10=most sever pain)

Visual Analogue Scale for pain measurement.

次要结局

未报告次要终点

研究者

发起方
South Egypt Cancer Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Alaa Ali M. Elzohry

Lecturer of Anesthesia, ICU and Pain Relief

Clinical Research Consultants, Inc.

研究点 (1)

Loading locations...

相似试验